Fruit Juice may Increase Aortic Blood Pressure and Heart Disease Risk
CHI HEALTH LETTER                October 17, 2014      
Fond of fruit juice? This new study might change the way you think about fruit juice and its benefits.


Published in the journal  Appetite, the new study found that frequent drinking of fruit juice contributes to excess sugar intake, which can worsen high blood pressure and lead to heart disease. The study measured the frequency of fruit juice intake among 160 adults within a 12-month period.


The findings suggest the daily use of fruit juice may increase central blood pressure (or aortic blood pressure), "which is known to be associated with cardiovascular disease risk and cognitive impairment,” according to Dr. Matthew Pase from the Swinburne University of Technology in Victoria, Australia.


Fruit juices contain high amounts of sugar – even comparable to sodas
– and no fiber. Another study found that, on average, fruit juice has a fructose concentration of 45.5g per liter, which is close to the average amount found in soda – 50g per liter. Constant intake of high amounts of sugar can eventually lead to insulin resistance, diabetes and obesity – all of which contribute to heart disease risk.


So if you are one of those people who like to drink fruit juices, now might be a good time to start eating fruits instead. If you eat an apple, for example, the sugar is balanced by the fiber, allowing your body to fully metabolize what you ingest. Taking a supplement like OxyPower will also help your body utilize sugar more efficiently and, most especially, it will help reduce blood pressure and heart disease risk.

OxyPower for Lowering Aortic Blood Pressure and Thickness

OxyPower is an herbal supplement consisting of the herbs, Hippophae and Rhodiola, that has been scientifically shown to help improve heart function and reduce cardiovascular disease risk as well as improve mitochondrial efficiency.

One study evaluated OxyPower’s effect on inflammation, blood pressure and intima media thickness. Group 1 was given only the CRP recombinant plasmid to induce inflammation. Group 2 was given an empty plasmid to serve as the negative control. Group 3 was given the CRP recombinant plasmid and OxyPower. The LVMI (Left ventricular mass index), IMT (Intima-media thickness or aortic thickness) and LVDP (Left ventricle diastolic pressure) were then measured.

Results (see table below) clearly show that there is thickening (or hypertrophy) of the both the left ventricle and the aorta (seen as high LVMI and IMT in the CRP+ group. Hypertrophy can reduce contractility of the heart and lower its ejection fraction, which eventually leads to heart failure. The table also shows elevated LVDP in the CRP+ group which means the left ventricle cannot be properly filled with blood because of hypertrophy that's why blood pressure increases. This can lead to high central (aortic) blood pressure as well.

With the addition of OxyPower to the CRP+ group, it is clear that OxyPower reduces inflammation/hypertrophy and blood pressure as seen in the reduced LVMI, IMT and LVDP. This will eventually lead to lower aortic blood pressure and reduced cardiovascular disease risk.

Case Reports: OxyPower on Heart Function


J.G., a 64 y/o/f from CA, has congestive heart failure. Her heart ejection fraction(volume of blood pumped out of the ventricle) at the time was 20% and she had difficulty breathing and driving. After taking OxyPower and Vein Lite for 6 months, her heart ejection fraction gradually increased to almost 50%. Now she doesn’t need a pacemaker. She can breathe easier, has no dizziness, has more energy and can drive


S. Layton, ND from TX, has a 60 y/o/f patient who had high BNP (Brain Natriuretic Peptide). A high BNP is a strong indicator of heart failure. After taking OxyPower and Vein Lite, the patient’s BNP reduced from 4500 to 2500.








P. Minkoff, MD from Florida has a 51 y/o/f patient with a high CRP level. After three months on OxyPower, her CRP reduced to within normal range.



G.




Adams, MD from FL, has a 66 y/o/m patient with high blood pressure. After taking OxyPower and Vein Lite for 3 months, his blood pressure normalized.






Try OxyPower now!

OxyPower improves Mitochondrial Efficacy for Better Glucose and Oxygen Use


When drinking fruit juice or even smoothies, the sugar and energy goes straight to the liver without any buffer. Over time, this can lead to insulin resistance and diabetes. It is therefore important for the body to be able to utilize glucose and energy efficiently in order to prevent this from happening. OxyPower can help.

In the mitochondrial electron transport chain, OxyPower improves the mechanism that transports fatty acids, glucose, and protons across mitochondrial membrane to produce ATP, the form of energy used by cells. This enables the cells to utilize glucose more effectively so there is no sugar overload and insulin can function properly. This particular function of OxyPower can lead to more long-lasting energy as well as HbA1c regulation.


Case Reports: OxyPower on Insulin Resistance


L.H., 65 y/o/f from New York, had a high fasting HbA1c level of 7.6. After 6 months on Diabend, OxyPower and Myomin, her HbA1c reduced to 6.5.








J.W., 69 y/o/f from New York, had insulin resistance symptoms and marginal HbA1c. After 6 months on Diabend and OxyPower, her HbA1c level reduced.\








Want more information on OxyPower? Get the new flyer and article now. Send your request to postmaster@chi-health.com



Or try OXYPOWER now!

EVENTS


PACIFIC SYMPOSIUM
November 7-9
Catamaran Resort Hotel
San Diego, CA
Booth #29

ANTI-AGING CONGRESS
December 11-13
Sands Expo and Convention Center
Las Vegas, NV
Booth #4039

Visit our EVENTS page for more details

Follow us on Facebook

Please be sure to LIKE our page on Facebook for updates and promotions!
 


Contact Us
Chi's Enterprise, Inc.
1435 N. Brasher Street
Anaheim, CA 92807

(714) 777-1542
www.chi-health.com
postmaster@chi-health.com



Share this